By Mike Montemarano, Associate Editor02.27.23
What if the health-promoting bioactives found in common herbs and botanicals could be produced without a square inch of soil?
Ayana Bio is setting a path to do just that, focusing on several high-yield bioactive ingredients that face production and sustainability challenges. In Sanskrit, “Ayana” can be interpreted as “good path.” In Swahili, “Ayana” is said to mean “beautiful flower.”
The company formed as a spinoff from Boston-based Ginkgo Bioworks (NYSE: DNA), a synthetic biology platform founded in 2008 by MIT scientists.
“Ginkgo Bioworks was launched to make bioengineering faster, cheaper, and easier across industries and applications through its cell programming platform,” said Frank Jaksch, who was appointed CEO of Ayana Bio in late 2022. “Through its partnership, Ayana Bio uses Ginkgo’s cell programming platform to rapidly analyze thousands of plant cell lines and find the highest-quality starting points for bioactives.”
Jaksch is the founder, pr
Ayana Bio is setting a path to do just that, focusing on several high-yield bioactive ingredients that face production and sustainability challenges. In Sanskrit, “Ayana” can be interpreted as “good path.” In Swahili, “Ayana” is said to mean “beautiful flower.”
The company formed as a spinoff from Boston-based Ginkgo Bioworks (NYSE: DNA), a synthetic biology platform founded in 2008 by MIT scientists.
“Ginkgo Bioworks was launched to make bioengineering faster, cheaper, and easier across industries and applications through its cell programming platform,” said Frank Jaksch, who was appointed CEO of Ayana Bio in late 2022. “Through its partnership, Ayana Bio uses Ginkgo’s cell programming platform to rapidly analyze thousands of plant cell lines and find the highest-quality starting points for bioactives.”
Jaksch is the founder, pr
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
